Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis Outbreaks Growing Issue in Non-Hospital Settings
ATLANTA, Jan. 5 -- Outbreaks of viral hepatitis are a growing problem in non-hospital healthcare facilities, such as nursing homes and hemodialysis clinics, the CDC has warned. Over the past decade, there have been 33 outbreaks of hepatitis B and C in

FDA Approves Most Comprehensive System To Test Donated Blood For HIV, Hepatitis B & Hepatitis C
The United States Food & Drug Administration (FDA) approved a new nucleic acid test from Roche to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and hepatitis B DNA in a single, automated assay. The test, called the cobas TaqScreen MPX Test

THATTA: Hepatitis on the rise in Thatta coastal areas
THATTA, Jan 4: As many as 362 new cases of hepatitis-C had been reported, most of them from remote coastal areas of the district, and various waterborne diseases were on the rise with over 90 per cent of water supply schemes not functioning, said

UPDATES AND COMMENTARY RSS Feed

Hepatitis C and Fibromyalgia: The Possible Link
Learn about the potential connection between Hepatitis C and fibromyalgia and find out why, due to similarities in manifestation and physiology, it is possible that Hepatitis C infection may act as one of fibromyalgia syndrome’s triggers. If you suspect having...

Hepatitis C Genotype Guides Health Plans
Because the suggested treatment length and success rates vary between genotypes, this is typically one of the first distinctions made after a Hepatitis C diagnosis. In order to assure the correct course of therapy is approved, health insurance companies are...

Math May Foretell Hepatitis C Drug Success
By doing a math formula calculation on the specific genetics of an individual's Hepatitis C infection, doctors may be able to predict whether or not treatment will be successful....

June 2003
Full Text Medical Articles


pdf format

You will need Adobe Acrobat Viewer
in order to view these articles.
Free Download


#1239 Hepatology highlights

  • Dietary Imbalance Promotes NASH
  • Itp-Associated Anti-Platelet Antibodies in Cirrhosis-Induced Thrombocytopenia
  • Cerebral Changes Following Simulation of a GI Bleed Support the Ammonia/Glutamine/Brain Swelling
    Hypothesis But May Result From Renal Rather Than Intestinal Ammonia Production
  • a Normal ALT Does Not Exclude Advanced Liver Disease Due to NASH
  • Polymorphisms of More Than One Biotransformation Step Combine to Promote Isoniazid Hepatotoxicity
  • © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1248 Hepatic stem cells &
    developmental biology of the liver

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1254 Nonselective Beta- blockers
    plus nitrates in portal hypertension:
    An open question

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1257 Viral kinetics in hepatitis C

    See Articles 1343 and 1351

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1260 Propranolol plus placebo
    versus propranolol plus isosorbide-5-mononitrate
    in the prevention of a first variceal bleed:
    A double-blind RCT

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1267 A role of autoantibody-mediated
    platelet destruction in thrombocytopenia
    in patients with cirrhosis

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1277 The kidney plays a major role in the
    hyperammonemia seen after simulated or
    actual GI bleeding in patients with cirrhosis

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1286 Clinical and histologic spectrum
    of nonalcoholic fatty liver disease
    associated with normal ALT values

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1293 All liver recipients benefit from
    the protocol 10-year liver biopsies

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1343 Viral dynamics and response differences
    in HCV-infected African American and
    white patients treated with IFN and ribavirin

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1351 Effect of ribavirin on hepatitis C viral
    kinetics in patients treated
    with pegylated interferon

    See Article 1257

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1359 Triple therapy with amantadine in
    treatment-naive patients with
    chronic hepatitis C:
    A placebo-controlled trial

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1368 A multicenter study of recombinant
    human interleukin 12 for the treatment
    of chronic hepatitis C virus infection
    in patients nonresponsive to previous therapy

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1470 New ways of interfering with HCV replication

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1472 Of chimps and men-
    finding the path to an HCV vaccine

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1493 Screening tests for hepatocellular carcinoma

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
    #1495 Prediction of spontaneous viral clearance
    in acute hepatitis C by viral load measurements

    © 2003 American Association for the Study of Liver Diseases.
    All rights reserved.
      Hep C information

    Information at this website is for educational purposes only; statements about products and health conditions
    have not been evaluated by the U.S. Food & Drug Administration.

    ©1994-2009 Hepatitis-Central.com
    Updated 06 Jan 2009